tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Keyur Parekh, 4 are a HOLD (33.33%), 8 are a BUY (66.67%).
Analyst Keyur Parekh, carries an average stock price target met ratio of 60% that have a potential upside of 39.78% achieved within 734 days. Previously, Keyur Parekh worked at GOLDMAN SACHS.
Keyur Parekh’s has documented 20 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/26/2022. The price target of $60.58 was fulfilled within 322 days with a profit of $19.07 (45.94%) receiving and performance score of 1.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$68.51 (39.95%)
$105
6 months 25 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$48.51 (28.29%)
$174
6 months 28 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-62.49 (-36.44%)
$168
7 months 23 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
11 months ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
11 months 28 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
